Amyris (AMRS) Misses Q4 EPS by 8c

Amyris (NASDAQ: AMRS) reported Q4 EPS of ($0.14), $0.08 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $38.72 million.

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c